drugset / Trial / NCT00943371
A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)
RandomizedParallel-groupDouble-blindTreatment
Summary
A single dose study to assess the safety, tolerability, pharmacokinetics and pharmacokinetics of MK6349 in Type 2 Diabetics.
Timeline
- Start
- 2007-08
- Primary completion
- 2007-09
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK6349 | Unknown | 16 mg | — |
| Subject | MK6349 | Unknown | 20 mg | — |
| Subject | MK6349 | Unknown | 50 mg | — |
| Subject | MK6349 | Unknown | 90 mg | — |
| Subject | MK6349 | Unknown | 160 mg | — |